Symptomatic Endometriosis Study

Assess efficacy and safety of three different doses of P2X3 antagonist in women with symptomatic endometriosis

Young Woman Suffering Stomach At Home

 

AGE: 18 years and over
GENDER: Female
TYPE: Drug Study
CONDITION: Premenopausal, Endometriosis
HEALTHY PARTICIPANTS: No
DEPARTMENT: Obstetrics & Gynecology
LOCATION: UH Cleveland Medical Center

Learn More About This Research Study

Please contact the MacDonald Clinical Trials Unit referral line at 440-995-3810 or fill out the form below to learn more about this study.

Study Purpose

The purpose of this study is to assess safety and efficacy of BAY 1817080 compared to elagolix and placebo in women with symptomatic endometriosis.

Who Can Participate

Women between 18 and 49 years of age who are premenopausal and are diagnosed with moderate to severe endometriosis may be eligible for this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.

XXX-XXX-XXXX